CBS 11 Header TXA 21 Header MeTV Header KRLD Header The Fan Header

News

FDA Approves Meningitis Vaccine For Infants

View Comments

CBS DFW (con't)

Affordable Care Act Updates: CBSDFW.com/ACA

Health News & Information: CBSDFW.com/Health

Get Breaking News First

Receive News, Politics, and Entertainment Headlines Each Morning.
Sign Up

From Our CBS Music Web Sites

kluvs super 70s weekend voting 1979 dl FDA Approves Meningitis Vaccine For InfantsPick The Best Song From 1979

115245513 8 FDA Approves Meningitis Vaccine For InfantsCrush Of The Day: Mila Kunis

80219448 FDA Approves Meningitis Vaccine For InfantsViral Video: Hilarious Southwest Safety Announcement

155742164 FDA Approves Meningitis Vaccine For InfantsPick Your Favorite Victoria Secret Model

Featured Items

Fantasy_tileHottest Olympians

pet_tileYour Pet Photos

weather_tileSend Us Your Weather Photos

NEW YORK (CBS NEWS) - A new combination vaccine that protects infants from two deadly infections that can cause meningitis, meningococcal disease and Hib disease, was approved Thursday by the U.S. Food and Drug Administration.

The vaccine, called Menhibrix, has been approved for children ages 6 weeks through 18 months old. It’s given as a four-dose series at 2, 4, 6 and 12 through 15 months of age, and the first dose may be given as early as 6 weeks of age. It is manufactured by GlaxoSmithKline.

Meningococcal disease is caused by the bacteria Neisseria meningitides, and is most commonly diagnosed among infants, adolescents and young adults. A common outcome of the infection is meningitis, a life-threatening infection of the covering that surrounds the brain and spinal cord. About 1,000 causes of meningococcal disease occur each year.

The bacteria spreads through respiratory and throat secretions like spit, but aren’t as contagious as the common cold or flu. Infants with meningococcal meningitis may appear to be slow or inactive, irritable, vomiting or feeding poorly, according to the Centers for Disease Control and Prevention.

Click Here To Read More From CBS News

Also Check Out:

View Comments